ORLANCE

Welcome to the Brand page for “ORLANCE”, which is offered here for Vaccines; vaccine preparations; medical preparations for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; pharmaceutical preparations and substances for the treatment of diseases and disorders, autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; chemical preparations for the treatment of diseases affecting mucosal tissues, the immune system, and respiratory tissues; chemical preparations for pharmaceutical purposes, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; chemical preparations for medical purposes, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer;medical services; medical testing for treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical evaluation services of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; medical treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer;medical devices to treat autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, tumors, and cancer; medical devices for administering vaccines pneumatically and parts thereof; vaccine apparatus comprised of devices for administering vaccines pneumatically; vaccine apparatus, automatic vaccination apparatus;research and development of vaccines; research and development of medicines, pharmaceutical research and development; research and development in the field of vaccination apparatus; medical research; scientific research; clinical research in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy, immune-oncology, chemotherapy, and anti-tumor agents;.

Its status is currently believed to be active. Its class is unavailable. “ORLANCE” is believed to be currently owned by “Orlance, Inc.”